Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: A retrospective observational study
Shoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai, et al.
Respiratory Investigation (2021) Vol. 59, Iss. 4, pp. 478-486
Closed Access | Times Cited: 21

Showing 21 citing articles:

Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy
Hiroyuki Nagase, Maho Suzukawa, Keiji Oishi, et al.
Allergology International (2022) Vol. 72, Iss. 1, pp. 11-23
Open Access | Times Cited: 62
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan
Carlo Lombardi, Pasquale Comberiati, Erminia Ridolo, et al.
Drugs (2024) Vol. 84, Iss. 6, pp. 661-684
Open Access | Times Cited: 10
Influence of Nurse-Led Health Education on Self-Management Ability, Satisfaction, and Compliance of Elderly Patients with Chronic Obstructive Pulmonary Disease Based on Knowledge, Belief, and Practice Model
Wenyan Hu, Tingyan Li, Shenglong Cao, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 23
Update on the pharmacological treatment of chronic obstructive pulmonary disease
Madeleine R. Jacques, Brooks Kuhn, Timothy E. Albertson
Expert Opinion on Pharmacotherapy (2024), pp. 1-20
Open Access | Times Cited: 4
Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)
Hiroyuki Nagase, Konomi Kobayashi, Makiko Toma‐Hirano, et al.
Allergology International (2025)
Open Access
Navigating biologic therapies in elderly asthma
HyeIn Ji, Laren Tan, George W. Hafzalla, et al.
Respiratory Medicine (2024) Vol. 227, pp. 107655-107655
Closed Access | Times Cited: 3
Aging-Related Mechanisms Contribute to Corticosteroid Insensitivity in Elderly Asthma
Maria L. Ford, Anushka Ruwanpathirana, Brandon W. Lewis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6347-6347
Open Access | Times Cited: 8
Management of Elderly Asthma: Key Questions and Tentative Answers
Heung‐Woo Park, Sang‐Heon Cho
Allergy Asthma and Immunology Research (2023) Vol. 15, Iss. 1, pp. 8-8
Open Access | Times Cited: 6
Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma
Vicky Kritikos, Erin S. Harvey, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 3, pp. 885-895.e13
Closed Access | Times Cited: 10
Monoclonal antibodies in type 2 asthma: an updated network meta-analysis
Ahmed Edris, Lies Lahousse
Minerva Medica (2021) Vol. 112, Iss. 5
Closed Access | Times Cited: 14
Characteristics of severe asthma patients on biologics: a real-life European registry study
Stefania Principe, Levi B. Richards, Simone Hashimoto, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00586-2022
Open Access | Times Cited: 5
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study
Ji‐Su Shim, Hyun‐Kyoung Kim, Jae‐Woo Kwon, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 12, pp. 100848-100848
Open Access | Times Cited: 4
Efficacy, Safety, and Continuation of Biological Therapy in Older Patients with Asthma in a Real-World Setting: A Retrospective Observational Study
Ryota Okazaki, Tomoya Harada, Yoshihiro Funaki, et al.
Yonago acta medica (2024) Vol. 67, Iss. 2, pp. 114-123
Open Access | Times Cited: 1
Clinical Characteristics of T2-Low and T2-High Asthma-Chronic Obstructive Pulmonary Disease Overlap: Findings From COREA Cohort
Ji‐Su Shim, S Y Kim, Sae‐Hoon Kim, et al.
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 6, pp. 601-601
Open Access | Times Cited: 1
Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study
Shoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai, et al.
Internal Medicine (2022) Vol. 61, Iss. 11, pp. 1663-1671
Open Access | Times Cited: 5
Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap
Nicola A. Hanania, Marc Miravitlles
Immunology and Allergy Clinics of North America (2022) Vol. 42, Iss. 3, pp. 657-669
Closed Access | Times Cited: 5
Role of IgE and Eosinophils: The Use of Type 2 Biomarkers in Practice
Hiroyuki Nagase, Hikaru Toyota
Respiratory disease series (2024), pp. 203-218
Closed Access
Potential Treatment Options for ACO, Including Biologics: Are There Any Roles of Biologics?
Nobuhisa Ishikawa
Respiratory disease series (2024), pp. 241-258
Closed Access
Epidemiology of ACO Defined by the JRS Guidelines: What Is the Prevalence of ACO in Japan?
Kuniaki Hirai, Hiroyuki Nagase
Respiratory disease series (2024), pp. 47-55
Closed Access
Asthma in the Elderly: Systematic Approach to Improve the Prognosis
Francisco-J. González-Barcala, Christian Calvo‐Henríquez, Gabriel Martínez‐Capoccioni, et al.
Barcelona Respiratory Network (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 1
When Asthma and Chronic Obstructive Pulmonary Disease Overlap; Current Knowledge and Unmet Needs
Louis‐Philippe Boulet, Nicola A. Hanania
Immunology and Allergy Clinics of North America (2022) Vol. 42, Iss. 3, pp. 499-505
Closed Access | Times Cited: 2
Page 1

Scroll to top